NCT03229265View on ClinicalTrials.gov

Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

August 7, 2019

Study Completion Date

August 7, 2019

Conditions
HyperkalemiaKidney Transplant
Interventions
DRUG

Patiromer

Patiromer (8.4 grams) will be taken daily at 3 hours after oral tacrolimus and MMF dosing by subjects commencing 3 days (± 1 day) prior to visit 1.

Trial Locations (1)

10021

The Rogosin Institute, New York

All Listed Sponsors
collaborator

Weill Medical College of Cornell University

OTHER

lead

The Rogosin Institute

OTHER

NCT03229265 - Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer | Biotech Hunter | Biotech Hunter